Literature DB >> 22696070

Enhancement of protease-induced IL-6 release in monocytic U-937 cells by phorbol-12-myristate-13-acetate.

A Domsalla1, Matthias F Melzig.   

Abstract

OBJECTIVE AND
DESIGN: Serine proteases and phorbol-12-myristate-13-acetate (PMA) are able to induce the release of pro-inflammatory interleukin-6 (IL-6) in monocytic cells. The present study was performed to investigate whether there is any interaction between proteases and phorbol ester in IL-6 release.
METHODS: U-937 cells differentiated with interferon-γ were treated with or without thrombin, trypsin, papain (each 1-10 μg/ml) and PMA (0.1-10 ng/ml) or the combination of both enzyme and PMA for up to 72 h and the release of IL-6 was determined by enzyme-linked immunosorbent assay.
RESULTS: Thrombin and PMA caused a time- and dose-dependent increase in IL-6. The combination of the two resulted in an increase up to fivefold higher than each agent alone. Even the combination of the cysteine protease papain and PMA showed a strong effect on IL-6 release compared to the individual tests.
CONCLUSIONS: These findings suggest a synergistic activity between phorbol ester and proteases to promote inflammation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22696070     DOI: 10.1007/s00011-012-0505-z

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  11 in total

Review 1.  Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody.

Authors:  K Yoshizaki; N Nishimoto; M Mihara; T Kishimoto
Journal:  Springer Semin Immunopathol       Date:  1998

2.  Thrombin regulates the expression of proangiogenic cytokines via proteolytic activation of protease-activated receptor-1.

Authors:  A Naldini; D H Carney; A Pucci; A Pasquali; F Carraro
Journal:  Gen Pharmacol       Date:  2000-11

3.  Thrombin receptor expression and responsiveness of human monocytic cells to thrombin is linked to interferon-induced cellular differentiation.

Authors:  A Naldini; L Sower; V Bocci; B Meyers; D H Carney
Journal:  J Cell Physiol       Date:  1998-10       Impact factor: 6.384

Review 4.  Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response.

Authors:  Martin Steinhoff; Jörg Buddenkotte; Victoria Shpacovitch; Anke Rattenholl; Corinna Moormann; Nathalie Vergnolle; Thomas A Luger; Morley D Hollenberg
Journal:  Endocr Rev       Date:  2005-02       Impact factor: 19.871

5.  Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line.

Authors:  P Biswas; F Delfanti; S Bernasconi; M Mengozzi; M Cota; N Polentarutti; A Mantovani; A Lazzarin; S Sozzani; G Poli
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

6.  Naive T cells sense the cysteine protease allergen papain through protease-activated receptor 2 and propel TH2 immunity.

Authors:  Genqing Liang; Tolga Barker; Zhihui Xie; Nicolas Charles; Juan Rivera; Kirk M Druey
Journal:  J Allergy Clin Immunol       Date:  2012-03-27       Impact factor: 10.793

Review 7.  Thrombin signalling and protease-activated receptors.

Authors:  S R Coughlin
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

Review 8.  Thrombin as a multi-functional enzyme. Focus on in vitro and in vivo effects.

Authors:  Jolanta M Siller-Matula; Michael Schwameis; Andrew Blann; Christine Mannhalter; Bernd Jilma
Journal:  Thromb Haemost       Date:  2011-10-06       Impact factor: 5.249

Review 9.  Phorbol esters: structure, biological activity, and toxicity in animals.

Authors:  Gunjan Goel; Harinder P S Makkar; George Francis; Klaus Becker
Journal:  Int J Toxicol       Date:  2007 Jul-Aug       Impact factor: 2.032

10.  Thrombin induces IL-6 production in fibroblasts and epithelial cells. Evidence for the involvement of the seven-transmembrane domain (STD) receptor for alpha-thrombin.

Authors:  L E Sower; C J Froelich; D H Carney; J W Fenton; G R Klimpel
Journal:  J Immunol       Date:  1995-07-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.